Carol Schafer – Biography
Last update: April 13, 2026Executive profile
Carol was Vice Chair, Equity Capital Markets at Wells Fargo Securities, and Vice President of Finance and Business Development at Lexicon Pharmaceuticals. Carol Schafer joined Insmed in 2024.
Carol Schafer is currentlyDirector at Immunome - View - Immunome org chart
Director at Insmed - View - Insmed org chart
Director at Kura Oncology - View - Kura Oncology org chart
Non-Executive Director and Chair of the Audit Committee at OMass Therapeutics - View - OMass Therapeutics org chart
Create your alert
to follow the career of Carol Schafer.
Education
Carol Schafer has a Master of Business Administration from New York University.
They have also studied at New York University :
Find more alumni from New York University
More about Carol Schafer
Selected links
Do you need to know more about Carol Schafer? More results.
Participate
Social media
- Carol Schafer on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Carol Schafer
The colleagues of Carol Schafer
Company Colleagues
- At Immunome, Carol Schafer has 28 colleagues including Clay Siegall (CEO & Chairman), Philip Wagenheim (Director)…
- At Insmed, Carol Schafer has 31 colleagues including Will Lewis (CEO & Chairman), Melvin Sharoky (Director)…
- At Kura Oncology, Carol Schafer has 28 colleagues including Troy Wilson (CEO & Chairman), Helen Collins (Director)…
- At OMass Therapeutics, Carol Schafer has 24 colleagues including Rosamond Deegan (CEO), Nathalie Franchimont (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Carol Schafer has 22,988 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Carol Schafer.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Carol Schafer.
